[Adenine-arabinoside in the treatment of idu-resistant herpes simplex keratitis (author's transl)].

Abstract	Fifteen cases of herpes simplex epithelial keratitis, which failed to heal following IDU therapy, were treated with Ara-A 3% ointment applied fives times daily. Epithelial disease resolved in fourteen cases with Ara-A and mean healing time was 6,6 days. No sign of ocular or adnexal toxicity were noted.
Authors	J Colin, G Baikoff, C Chastel, G Renard
Journal	Journal francais d'ophtalmologie (J Fr Ophtalmol) Vol. 2 Issue 3 Pg. 205-7 (Mar 1979) ISSN: 0181-5512 [Print] France
Vernacular Title	L'adénine-arabinoside dans le traitement des kératites herpétiques IDU-résistantes.
PMID	156754 (Publication Type: English Abstract, Journal Article)
Chemical References	Ointments Vidarabine Idoxuridine
Topics	Administration, Topical Adolescent Adult Aged Child Child, Preschool Drug Evaluation Drug Resistance, Microbial Humans Idoxuridine (therapeutic use) Keratitis, Dendritic (drug therapy) Middle Aged Ointments Vidarabine (administration & dosage, adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!